Novo Nordisk has been creating innovative medicines and delivery systems to meet the medical needs of people living with serious chronic disease for almost 100 years.

In that time they have produced 1 billion insulin pens. They currently produce 50% of the world's insulin supply and 30 million people use their diabetes care products.